FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to experimental medicine, cell biology. As a stimulator of fetal weight in a pregnant rat on the 9th or 10th or 11th day of pregnancy, subcutaneously inject 100 mcl of a suspension of human umbilical cord blood mononuclear cells containing 6.9 million cells into the area of each nipple of the breast. Total number of injected cells should be 69 million human umbilical cord blood cells in a volume of 1,000 mcl.
EFFECT: method allows to expand the arsenal of existing means to stimulate the fetal weight in the experiment and in clinical practice after obtaining permission for the clinical use of this method, and also to eliminate the use of anesthesia in a pregnant woman in the early stages of her pregnancy.
1 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR STIMULATION OF ENDOMETRIAL DECIDUA FORMATION EXPERIMENTALLY | 2012 |
|
RU2515475C1 |
METHOD OF PRODUCING ENDOMETRIAL STEM CELLS OF THE PERSON INTENDED FOR TISSUE NEOGENESIS | 2014 |
|
RU2595375C2 |
METHOD FOR STIMULATING SPINAL CORD REGENERATION WITH GENETICALLY MODIFIED HUMAN UMBILICAL CORD BLOOD CELLS | 2013 |
|
RU2521225C2 |
METHOD FOR PREDICTING INTRAVENTRICULAR HEMORRHAGE IN PREMATURE INFANTS BORN FROM MOTHERS WITH PREECLAMPSIA | 2022 |
|
RU2792565C1 |
METHOD FOR CHOOSING MANAGEMENT APPROACH TO PREGNANT WOMEN WITH PLACENTAL INSUFFICIENCY AND FOETAL GROWTH RETARDATION SYNDROME (FGRS) | 2015 |
|
RU2595884C1 |
METHOD FOR PREVENTING CHRONIC HYPOXIA AND FOETAL DEVELOPMENT RETARDATION | 2018 |
|
RU2699559C2 |
METHOD OF STIMULATION OF IMPAIRED SPERMATOGENESIS AND SYNTHESIS OF TESTOSTERONE USING TRANSPLANTATION OF THE NEONATAL TESTICULAR TISSUE | 2017 |
|
RU2669027C1 |
METHOD OF PREDICTING SHIFT IN ACID-BASE BALANCE OF FETAL BLOOD DURING PREGNANCY | 2023 |
|
RU2810176C1 |
METHOD FOR PREDICTION OF PREMATURE ABRUPTION OF NORMALLY LOCATED PLACENTA | 2024 |
|
RU2825067C1 |
METHOD FOR PREDICTING EARLY FETAL GROWTH RETARDATION ACCORDING TO PLACENTOMETRY AT 19-21 WEEKS OF GESTATION IN LOW-RISK PATIENTS | 2022 |
|
RU2795084C1 |
Authors
Dates
2018-12-18—Published
2018-04-02—Filed